I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 8 studies | 31% ± 11% | |
| non-classical monocyte | 7 studies | 25% ± 7% | |
| epithelial cell | 3 studies | 22% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 8 studies | 31% ± 11% | |
| non-classical monocyte | 7 studies | 25% ± 7% | |
| epithelial cell | 3 studies | 22% ± 7% |
Insufficient scRNA-seq data for expression of CALML4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 643.07 | 1444 / 1445 | 3% | 0.04 | 5 / 183 |
| intestine | 100% | 1588.66 | 966 / 966 | 1% | 0.01 | 4 / 527 |
| bladder | 100% | 232.71 | 21 / 21 | 1% | 0.01 | 3 / 504 |
| ovary | 100% | 227.28 | 180 / 180 | 0% | 0.00 | 1 / 430 |
| kidney | 100% | 1042.19 | 89 / 89 | 0% | 0.00 | 2 / 901 |
| uterus | 100% | 292.82 | 170 / 170 | 0% | 0.00 | 1 / 459 |
| breast | 100% | 308.59 | 459 / 459 | 0% | 0.00 | 1 / 1118 |
| adrenal gland | 100% | 310.88 | 258 / 258 | 0% | 0 | 0 / 230 |
| liver | 100% | 346.35 | 226 / 226 | 0% | 0 | 0 / 406 |
| prostate | 100% | 482.98 | 245 / 245 | 0% | 0 | 0 / 502 |
| spleen | 100% | 580.71 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 325.29 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| lung | 100% | 347.65 | 576 / 578 | 0% | 0.00 | 3 / 1155 |
| thymus | 100% | 242.80 | 652 / 653 | 0% | 0 | 0 / 605 |
| skin | 100% | 258.78 | 1804 / 1809 | 0% | 0 | 0 / 472 |
| pancreas | 99% | 262.24 | 325 / 328 | 0% | 0 | 0 / 178 |
| stomach | 99% | 330.57 | 354 / 359 | 0% | 0.00 | 1 / 286 |
| peripheral blood | 97% | 376.50 | 901 / 929 | 0% | 0 | 0 / 0 |
| brain | 91% | 160.72 | 2406 / 2642 | 0% | 0 | 0 / 705 |
| blood vessel | 87% | 131.84 | 1162 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 82% | 115.54 | 658 / 803 | 0% | 0 | 0 / 0 |
| heart | 76% | 85.42 | 652 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_1904970 | Biological process | brush border assembly |
| GO_0005902 | Cellular component | microvillus |
| GO_0032028 | Molecular function | myosin head/neck binding |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0030234 | Molecular function | enzyme regulator activity |
| Gene name | CALML4 |
| Protein name | Calmodulin-like protein 4 Calmodulin like 4 Calmodulin like 4 (Calmodulin-like 4, isoform CRA_a) Calmodulin-like protein 4 (Serologically defined breast cancer antigen NY-BR-20) |
| Synonyms | hCG_23814 |
| Description | FUNCTION: As part of the intermicrovillar adhesion complex/IMAC plays a role in epithelial brush border differentiation, controlling microvilli organization and length. Acts as a light chain for MYO7B and is required for efficient targeting of the IMAC to the tips of border brush microvilli. . |
| Accessions | H3BM29 ENST00000354678.3 A0A804DNR1 ENST00000467889.3 ENST00000395463 ENST00000448060.7 H3BS46 ENST00000395463.3 [Q96GE6-2] A0A804D2Q3 Q96GE6 ENST00000540479.6 [Q96GE6-3] |
